GSK Sells Remaining Stake In Advil Maker Haleon For £1.25B
GSK PLC said on Friday that it has sold its remaining 4.2% stake in its spun-off consumer healthcare unit Haleon PLC for £1.25 billion ($1.6 billion)....To view the full article, register now.
Already a subscriber? Click here to view full article